Michael J McGann's Insider Trades & SAST Disclosures
Michael J McGann's most recent trade in Xylem Inc was a trade of 5,751 Non-Qualified Stock Options (Right to buy) done . Disclosure was reported to the exchange on March 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael J McGann.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xylem Inc | Michael J. McGann | SVP & President, MCS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 5,751 | 5,751 | - | - | Non-Qualified Stock Options (Right to buy) | |
| Xylem Inc | Michael J. McGann | SVP & President, MCS | Grant, award, or other acquisition of securities at price $ 129.67 per share. | 05 Mar 2025 | 1,639 | 8,180 (0%) | 0% | 129.7 | 212,529 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Grant, award, or other acquisition of securities at price $ 129.78 per share. | 01 Mar 2025 | 630 | 7,491 (0%) | 0% | 129.8 | 81,761 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Grant, award, or other acquisition of securities at price $ 129.78 per share. | 01 Mar 2025 | 630 | 6,861 (0%) | 0% | 129.8 | 81,761 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 129.78 per share. | 01 Mar 2025 | 544 | 6,947 (0%) | 0% | 129.8 | 70,600 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Grant, award, or other acquisition of securities at price $ 129.78 per share. | 01 Mar 2025 | 526 | 6,231 (0%) | 0% | 129.8 | 68,264 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 129.78 per share. | 01 Mar 2025 | 406 | 6,541 (0%) | 0% | 129.8 | 52,691 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 5,619 | 5,619 | - | - | Stock Options (Right to buy) | |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Grant, award, or other acquisition of securities at price $ 127.94 per share. | 01 Mar 2024 | 1,661 | 5,681 (0%) | 0% | 127.9 | 212,508 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Grant, award, or other acquisition of securities at price $ 127.94 per share. | 01 Mar 2024 | 814 | 5,098 (0%) | 0% | 127.9 | 104,143 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.94 per share. | 01 Mar 2024 | 610 | 4,488 (0%) | 0% | 127.9 | 78,043 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Grant, award, or other acquisition of securities at price $ 127.94 per share. | 01 Mar 2024 | 501 | 4,284 (0%) | 0% | 127.9 | 64,098 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.94 per share. | 01 Mar 2024 | 468 | 4,020 (0%) | 0% | 127.9 | 59,876 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 6,452 | 6,452 | - | - | Stock Option (Right to buy) | |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,855 | 3,771 (0%) | 0% | 0 | Common Stock | |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.09 per share. | 01 Mar 2023 | 132 | 1,916 (0%) | 0% | 101.1 | 13,344 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 1,136 | 2,501 (0%) | 0% | 0 | Common Stock | |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.55 per share. | 27 Feb 2023 | 386 | 2,115 (0%) | 0% | 102.5 | 39,584 | Common Stock |
| Xylem Inc | Michael J. McGann | SVP & President Americas & MCS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.55 per share. | 27 Feb 2023 | 67 | 2,048 (0%) | 0% | 102.6 | 6,871 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges